PT Merck Tbk Statistics
Total Valuation
PT Merck Tbk has a market cap or net worth of IDR 1.44 trillion. The enterprise value is 1.28 trillion.
| Market Cap | 1.44T |
| Enterprise Value | 1.28T |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | Jun 25, 2025 |
Share Statistics
PT Merck Tbk has 448.00 million shares outstanding.
| Current Share Class | 448.00M |
| Shares Outstanding | 448.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 59.81M |
Valuation Ratios
The trailing PE ratio is 8.06.
| PE Ratio | 8.06 |
| Forward PE | n/a |
| PS Ratio | 1.31 |
| PB Ratio | 1.73 |
| P/TBV Ratio | 1.73 |
| P/FCF Ratio | 7.89 |
| P/OCF Ratio | 6.95 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.97, with an EV/FCF ratio of 7.03.
| EV / Earnings | 7.18 |
| EV / Sales | 1.17 |
| EV / EBITDA | 4.97 |
| EV / EBIT | 5.68 |
| EV / FCF | 7.03 |
Financial Position
The company has a current ratio of 6.76, with a Debt / Equity ratio of 0.02.
| Current Ratio | 6.76 |
| Quick Ratio | 3.59 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.08 |
| Interest Coverage | 81.40 |
Financial Efficiency
Return on equity (ROE) is 22.84% and return on invested capital (ROIC) is 17.67%.
| Return on Equity (ROE) | 22.84% |
| Return on Assets (ROA) | 14.81% |
| Return on Invested Capital (ROIC) | 17.67% |
| Return on Capital Employed (ROCE) | 25.77% |
| Revenue Per Employee | 2.97B |
| Profits Per Employee | 483.75M |
| Employee Count | 376 |
| Asset Turnover | 1.15 |
| Inventory Turnover | 1.74 |
Taxes
In the past 12 months, PT Merck Tbk has paid 49.68 billion in taxes.
| Income Tax | 49.68B |
| Effective Tax Rate | 21.77% |
Stock Price Statistics
The stock price has decreased by -7.76% in the last 52 weeks. The beta is -0.11, so PT Merck Tbk's price volatility has been lower than the market average.
| Beta (5Y) | -0.11 |
| 52-Week Price Change | -7.76% |
| 50-Day Moving Average | 2,974.60 |
| 200-Day Moving Average | 3,151.55 |
| Relative Strength Index (RSI) | 69.85 |
| Average Volume (20 Days) | 53,605 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Merck Tbk had revenue of IDR 1.10 trillion and earned 178.51 billion in profits. Earnings per share was 398.45.
| Revenue | 1.10T |
| Gross Profit | 440.53B |
| Operating Income | 225.63B |
| Pretax Income | 228.18B |
| Net Income | 178.51B |
| EBITDA | 250.83B |
| EBIT | 225.63B |
| Earnings Per Share (EPS) | 398.45 |
Balance Sheet
The company has 171.79 billion in cash and 15.15 billion in debt, giving a net cash position of 156.64 billion or 349.65 per share.
| Cash & Cash Equivalents | 171.79B |
| Total Debt | 15.15B |
| Net Cash | 156.64B |
| Net Cash Per Share | 349.65 |
| Equity (Book Value) | 833.21B |
| Book Value Per Share | 1,859.85 |
| Working Capital | 647.46B |
Cash Flow
In the last 12 months, operating cash flow was 206.94 billion and capital expenditures -24.58 billion, giving a free cash flow of 182.37 billion.
| Operating Cash Flow | 206.94B |
| Capital Expenditures | -24.58B |
| Free Cash Flow | 182.37B |
| FCF Per Share | 407.07 |
Margins
Gross margin is 40.15%, with operating and profit margins of 20.57% and 16.27%.
| Gross Margin | 40.15% |
| Operating Margin | 20.57% |
| Pretax Margin | 20.80% |
| Profit Margin | 16.27% |
| EBITDA Margin | 22.86% |
| EBIT Margin | 20.57% |
| FCF Margin | 16.62% |
Dividends & Yields
This stock pays an annual dividend of 170.00, which amounts to a dividend yield of 5.31%.
| Dividend Per Share | 170.00 |
| Dividend Yield | 5.31% |
| Dividend Growth (YoY) | -46.88% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 42.74% |
| Buyback Yield | n/a |
| Shareholder Yield | 5.31% |
| Earnings Yield | 12.41% |
| FCF Yield | 12.68% |
Stock Splits
The last stock split was on December 21, 2015. It was a forward split with a ratio of 20.
| Last Split Date | Dec 21, 2015 |
| Split Type | Forward |
| Split Ratio | 20 |
Scores
PT Merck Tbk has an Altman Z-Score of 9.57 and a Piotroski F-Score of 7.
| Altman Z-Score | 9.57 |
| Piotroski F-Score | 7 |